Trevi Therapeutics Announces Election of Dominick C. Colangelo to Board of Directors
June 30, 2020 16:45 ET
|
Trevi Therapeutics
NEW HAVEN, Conn., June 30, 2020 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (“Trevi”), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER...